Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus delayed salvage radiotherapy plus short-term triptorelin after prostatectomy for intermediate-risk pT3 R1 prostate cancer
2007-002495-34Phase 3Terminated
- Sponsor
- Unicancer
- Start
- Aug 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triptorelin in prostate adenocarcinoma (2 arms), sponsored by Unicancer. Primary endpoint: Event-free survival. Started Aug 2007; status: terminated.
02
Drugs
triptorelin
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on 2007-002495-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002495-34.